OQS
CYTK icon

Occudo Quantitative Strategies’s Cytokinetics CYTK Stock Holding History

Occudo Quantitative Strategies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,610
Closed -$358K – 770
2024
Q2 		$358K Buy
+6,610
New +$399K 0.06% 401
2024
Q1 		– Sell
-15,764
Closed -$1.32M – 795
2023
Q4 		$1.32M Buy
+15,764
New +$571K 0.18% 159
2022
Q3 		– Sell
-22,347
Closed -$878K – 1230
2022
Q2 		$878K Sell
22,347
-7,586
-25% -$305K 0.07% 425
2022
Q1 		$1.1M Buy
29,933
+2,985
+11% +$106K 0.09% 353
2021
Q4 		$1.23M Sell
26,948
-2,791
-9% -$108K 0.11% 288
2021
Q3 		$1.06M Buy
+29,739
New +$876K 0.13% 262

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Occudo Quantitative Strategies's CYTK Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of Cytokinetics (CYTK) in Q3 2024, closing a stake of 6,610 shares — an estimated $358K sold.

Occudo Quantitative Strategies first reported a position in CYTK in Q3 2021 and held it in 6 quarters. The position peaked at $1.32M in Q4 2023. 347 funds tracked by Wall St. Rank hold CYTK as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining Cytokinetics position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,610 Cytokinetics shares in Q3 2024, an estimated $358K.
  • Occudo Quantitative Strategies first reported a position in Cytokinetics in Q3 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Cytokinetics position peaked at $1.32M in Q4 2023.
  • 347 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.